1.Control of clonorchiasis by repeated praziquantel treatment and low diagnostic efficacy of sonography.
Sung Tae HONG ; Kisung YOON ; Mejeong LEE ; Min SEO ; Min Ho CHOI ; Jung Suk SIM ; Byung Ihn CHOI ; Chong Ku YUN ; Soon Hyung LEE
The Korean Journal of Parasitology 1998;36(4):249-254
In Korea, Clonorchis sinensis infection is still highly prevalent because case detection in the field is difficult and the detected cases used to be incompletely cured due to treatment failure. The present study tried to control clonorchiasis in an endemic village by repeated treatments with praziquantel every 6 months and to evaluate sonography as a diagnostic measure. By stool examinations, the egg positive rate in the endemic village was 22.7%, but it decreased to 19.6% at 6 months, 15.1% at 12 months. 12.2% at 18 months, 6.3% at 24 months, 11.4% at 30 months, and 6.3% at 42 months after the beginning of repeated praziquantel administration. The sonography showed 61 (49.6%) positive cases of 123 screened residents: among egg-positives the sonography positive rate was 52.2% and among egg-negatives it was still 49%. The rate among cured cases was 64.3% after 6 months, 50.0% after 12 months, 50.0% after 18 months, and 66.7% after 24 months. In a non-endemic village, 64 residents were found egg-negative by fecal examination, but 20 (31.3%) of them were positive by sonography. The present findings indicate that control of clonorchiasis in an endemic village by repeated praziquantel treatment for 42 months is still insufficient and sonography is of little value for diagnosis of clonorchiasis.
Animal
;
Antiplatyhelmintic Agents/administration & dosage*
;
Clonorchiasis/ultrasonography*
;
Clonorchiasis/prevention & control
;
Clonorchiasis/epidemiology
;
Follow-Up Studies
;
Human
;
Korea/epidemiology
;
Parasite Egg Count
;
Praziquantel/administration & dosage*
;
Prevalence
;
Sensitivity and Specificity
;
Treatment Failure
2.Liver Fluke-Associated Biliary Tract Cancer.
Piyapan PRUEKSAPANICH ; Panida PIYACHATURAWAT ; Prapimphan AUMPANSUB ; Wiriyaporn RIDTITID ; Roongruedee CHAITEERAKIJ ; Rungsun RERKNIMITR
Gut and Liver 2018;12(3):236-245
Cholangiocarcinoma (CCA) is an aggressive cancer arising from epithelial cells of the bile duct. Most patients with CCA have an unresectable tumor at the time of diagnosis. In Western countries, the risk of CCA increases in patients with primary sclerosing cholangitis, whereas liver fluke infection appears to be the major risk factor for CCA in Asian countries. A diagnosis of liver fluke infection often relies on stool samples, including microscopic examination, polymerase chain reaction-based assays, and fluke antigen detection. Tests of serum, saliva and urine samples are also potentially diagnostic. The presence of liver fluke along with exogenous carcinogens magnifies the risk of CCA in people living in endemic areas. The “liver fluke-cholangiocarcinoma” carcinogenesis pathways consist of mechanical damage to the bile duct epithelium, immunopathologic and cellular reactions to the liver fluke's antigens and excretory/secretory products, liver fluke-induced changes in the biliary tract microbiome and the effects of repeated treatment for liver fluke. A vaccine and novel biomarkers are needed for the primary and secondary prevention of CCA in endemic areas. Importantly, climate change exerts an effect on vector-borne parasitic diseases, and awareness of liver fluke should be enhanced in potentially migrated habitat areas.
Asian Continental Ancestry Group
;
Bile Ducts
;
Biliary Tract Neoplasms*
;
Biliary Tract*
;
Biomarkers
;
Carcinogenesis
;
Carcinogens
;
Cholangiocarcinoma
;
Cholangitis, Sclerosing
;
Climate Change
;
Clonorchiasis
;
Diagnosis
;
Ecosystem
;
Epithelial Cells
;
Epithelium
;
Fasciola hepatica
;
Humans
;
Liver*
;
Microbiota
;
Opisthorchiasis
;
Parasitic Diseases
;
Risk Factors
;
Saliva
;
Secondary Prevention
;
Trematoda